Lucid Diagnostics Inc. financial data

Symbol
LUCD on Nasdaq
Location
360 Madison Avenue, 25 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 110 % -43.1%
Debt-to-equity 351 % +341%
Return On Equity -664 % -164%
Return On Assets -147 % -5.17%
Operating Margin -1.17K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.2M shares +21.8%
Common Stock, Shares, Outstanding 49.3M shares +17.9%
Entity Public Float 14.4M USD -23.8%
Common Stock, Value, Issued 49K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 48.2M shares +15.2%
Weighted Average Number of Shares Outstanding, Diluted 48.2M shares +15.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.8M USD +514%
Revenue from Contract with Customer, Excluding Assessed Tax 3.8M USD +514%
Cost of Revenue 369K USD
Research and Development Expense 6.41M USD -26%
Selling and Marketing Expense 16.6M USD -2.65%
General and Administrative Expense 17.5M USD -21.1%
Operating Income (Loss) -44.6M USD +19.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -46.7M USD +18%
Net Income (Loss) Attributable to Parent -46.7M USD +18%
Earnings Per Share, Basic -1.22 USD/shares +16.4%
Earnings Per Share, Diluted -1.22 USD/shares +14.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.9M USD -23.5%
Accounts Receivable, after Allowance for Credit Loss, Current 160K USD +357%
Inventory, Net 683K USD
Assets, Current 27.9M USD -21.8%
Property, Plant and Equipment, Net 1.05M USD -24.4%
Operating Lease, Right-of-Use Asset 3.04M USD +65.5%
Intangible Assets, Net (Excluding Goodwill) 947K USD -61.1%
Other Assets, Noncurrent 1.13M USD +5.01%
Assets 34.1M USD -19.7%
Accounts Payable, Current 903K USD +41.8%
Employee-related Liabilities, Current 1.18M USD +34%
Liabilities, Current 16M USD -40.1%
Operating Lease, Liability, Noncurrent 2.15M USD +194%
Liabilities 18.1M USD -33.9%
Retained Earnings (Accumulated Deficit) -180M USD -43.1%
Stockholders' Equity Attributable to Parent 16M USD +6.03%
Liabilities and Equity 34.1M USD -19.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.6M USD -77.1%
Net Cash Provided by (Used in) Financing Activities 18.5M USD -23.4%
Net Cash Provided by (Used in) Investing Activities -37K USD -118%
Common Stock, Shares Authorized 300M shares +50%
Common Stock, Shares, Issued 49.3M shares +17.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.87M USD -65.6%
Deferred Tax Assets, Valuation Allowance 42.2M USD +62.2%
Deferred Tax Assets, Gross 42.2M USD +62.2%
Operating Lease, Liability 3.04M USD +65.9%
Depreciation 24K USD +700%
Payments to Acquire Property, Plant, and Equipment 17K USD -88.5%
Lessee, Operating Lease, Liability, to be Paid 3.44M USD +75.9%
Property, Plant and Equipment, Gross 2.1M USD +11.7%
Operating Lease, Liability, Current 884K USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 952K USD +650%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.02M USD -10.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 406K USD +220%
Lessee, Operating Lease, Liability, to be Paid, Year Three 913K USD +1349%
Deferred Tax Assets, Operating Loss Carryforwards 29.1M USD +81.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1K USD -95.8%
Operating Lease, Payments 305K USD +7.02%
Additional Paid in Capital 140M USD +10%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.49M USD -79.2%
Depreciation, Depletion and Amortization 501K USD -18.1%
Deferred Tax Assets, Net of Valuation Allowance 42.2M USD +62.2%
Share-based Payment Arrangement, Expense 4.35M USD -63.5%
Interest Expense 178K USD -97.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%